Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Gordon Carl L

Over the trailing 90 days, Gordon Carl L (Director at Scribe Therapeutics, Inc.) bought $15.0M of stock in SCTX, per 4 SEC Form 4 transactions.

Role: Director
Companies: SCTX
Window: Trailing 90 days · 4 transactions · CIK 1282930
Net activity: +$15.0M ($15.0M bought · $0 sold)
Source: Official filings on sec.gov ↗

By Company (Trailing 90 Days)

Symbol	Company	Txns	Bought	Sold	Net
SCTX	Scribe Therapeutics, Inc.	4	$15.0M	—	$15.0M

Transactions (4)

Date	Symbol	Type	Shares	Value	Description
2026-07-27	SCTX	Buy	348.8K	$0	Conversion of derivative security
2026-07-27	SCTX	Buy	1.0M	$15.0M	Open market or private purchase
2026-07-27	SCTX	Sell	2.1M	$0	Conversion of derivative security
2026-07-23	SCTX	Buy	14.7K	$0	Grant, award or other acquisition

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Gordon's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free